Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders.
Arnim Johannes GaeblerGeorgios SchoretsanitisNagia Ben OmarEkkehard HaenKatharina EndresChristoph HiemkeMichael PaulzenPublished in: British journal of clinical pharmacology (2020)
Our findings support preliminary evidence that metamizole acts as a potent inductor of cytochrome P450 isoenzymes CYP2B6 and CYP3A4. We observed a clinically meaningful pharmacokinetic interaction between metamizole and sertraline, leading to insufficiently low sertraline drug concentrations. Clinicians should therefore consider alternative drug combinations or apply TDM-guided dose adjustment of sertraline.